| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.099 | 0.07 |